TRex Bio
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
About TRex Bio
TRexBio is a biotechnology company that leverages cutting-edge computational biology tools, a focus on human tissue, and expertise in immunobiology to develop therapeutics for cancer and inflammatory diseases. Its 'deep biology' discovery engine maps human tissue Treg behavior to disease processes, identifying and characterizing novel targets for therapeutic intervention. The platform supports the development of a portfolio of therapies that modulate the immune system to restore tissue immune homeostasis.
Company Facts
- Headquarters
- South San Francisco
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $169,000,000
- Last Funding Type
- series_b
- Last Funding Date
- 2024-11-13
- Website
- trex.bio
Industries & Categories
Bioinformatics, Biopharma, Biotechnology
Social Links
Canonical: https://fsome.com/organization/trex-bio-87255 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.